Biomerica, Inc.
BMRA
$2.18
$0.020.93%
NASDAQ
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -23.81% | -20.05% | -11.31% | -1.88% | 5.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -23.81% | -20.05% | -11.31% | -1.88% | 5.05% |
| Cost of Revenue | -15.75% | -15.49% | -15.41% | 0.10% | 2.61% |
| Gross Profit | -75.56% | -58.12% | 31.13% | -17.60% | 23.99% |
| SG&A Expenses | -2.55% | -12.83% | -19.20% | -15.88% | -15.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.19% | -15.19% | -18.67% | -11.33% | -10.79% |
| Operating Income | -4.98% | 10.60% | 24.89% | 19.36% | 23.62% |
| Income Before Tax | 14.30% | 28.20% | 40.48% | 16.26% | 23.09% |
| Income Tax Expenses | 425.00% | -25.00% | -95.65% | -95.24% | -91.67% |
| Earnings from Continuing Operations | 13.94% | 28.19% | 40.68% | 16.81% | 23.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.94% | 28.19% | 40.68% | 16.81% | 23.61% |
| EBIT | -4.98% | 10.60% | 24.89% | 19.36% | 23.62% |
| EBITDA | -5.13% | 10.73% | 25.28% | 19.71% | 24.03% |
| EPS Basic | 28.76% | 38.37% | 44.45% | 20.70% | 26.44% |
| Normalized Basic EPS | 29.03% | 38.36% | 44.25% | 20.17% | 25.95% |
| EPS Diluted | 27.51% | 37.44% | 43.65% | 20.32% | 26.74% |
| Normalized Diluted EPS | 29.03% | 38.36% | 44.25% | 20.17% | 25.95% |
| Average Basic Shares Outstanding | 23.07% | 20.13% | 11.54% | 5.18% | 4.34% |
| Average Diluted Shares Outstanding | 23.07% | 20.13% | 11.54% | 5.18% | 4.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |